A Study of SYS6010 in Combination With SYH2051 in Patients With Advanced Colorectal Cancer and Other Gastrointestinal Tumors

NCT07104877 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

25

Enrollment

OTHER_GOV

Sponsor class

Conditions

Colorectal Cancer
Gastric Cancer (GC)
Gastrointestinal Tumors

Interventions

DRUG: SYS6010
DRUG: SYH2051

Sponsor

Fujian Cancer Hospital